These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 17365655
1. Cure of disseminated zygomycosis with cerebral involvement using high dose liposomal amphotericin B and surgery. Revankar SG, Hasan MS, Smith JW. Med Mycol; 2007 Mar; 45(2):183-5. PubMed ID: 17365655 [Abstract] [Full Text] [Related]
2. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B. Vazquez L, Mateos JJ, Sanz-Rodriguez C, Perez E, Caballero D, San Miguel JF. Haematologica; 2005 Dec; 90(12 Suppl):ECR39. PubMed ID: 16464754 [Abstract] [Full Text] [Related]
3. Disseminated zygomycosis with involvement of the central nervous system. Skiada A, Vrana L, Polychronopoulou H, Prodromou P, Chantzis A, Tofas P, Daikos GL. Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():46-9. PubMed ID: 19754757 [Abstract] [Full Text] [Related]
4. Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole. Bourke P, Castro P, Rabagliati R, Beltran C, Verdejo H, Winter JL, Bourge RC. Transpl Infect Dis; 2012 Oct; 14(5):E56-9. PubMed ID: 22852999 [Abstract] [Full Text] [Related]
10. Lipid formulations of amphotericin B as first-line treatment of zygomycosis. Petrikkos GL. Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():87-92. PubMed ID: 19754765 [Abstract] [Full Text] [Related]
11. Severe cutaneous zygomycosis: evaluation of treatment with high doses of liposomal amphotericin B in a one-year old child. Bandettini R, Tuo P, Tamisani AM, Di Marco E, Mantero E. J Chemother; 2007 Jun; 19(3):347-9. PubMed ID: 17594934 [No Abstract] [Full Text] [Related]
14. AmBisome today: expanding the perspectives on liposomal amphotericin B. Richardson M. Acta Biomed; 2006 Jun; 77 Suppl 2():3-4. PubMed ID: 16918058 [No Abstract] [Full Text] [Related]
15. Comparison of lipid amphotericin B preparations in treating murine zygomycosis. Ibrahim AS, Gebremariam T, Husseiny MI, Stevens DA, Fu Y, Edwards JE, Spellberg B. Antimicrob Agents Chemother; 2008 Apr; 52(4):1573-6. PubMed ID: 18227182 [Abstract] [Full Text] [Related]
16. Acute wound closure and reconstruction following head zygomycosis: presentation of two cases and review of literature. Adler N, Seitz IA, Gottlieb LJ. J Reconstr Microsurg; 2008 Oct; 24(7):507-13. PubMed ID: 18798145 [Abstract] [Full Text] [Related]
17. Diagnosis and treatment of cutaneous zygomycosis. Visser DH, van den Berg YL, van Furth AM, Oomen MW, Schouten-van Meeteren AY, Pajkrt D, van den Bos C, van Well GT. Pediatr Infect Dis J; 2007 Dec; 26(12):1165-6. PubMed ID: 18043463 [Abstract] [Full Text] [Related]
18. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient. Crompton JA, Alexander D, Somerville T, Shihab FS. Transpl Infect Dis; 2004 Dec; 6(4):183-7. PubMed ID: 15762937 [Abstract] [Full Text] [Related]
19. Improved outcome of zygomycosis in patients with hematological diseases? Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Leuk Lymphoma; 2004 Jul; 45(7):1351-60. PubMed ID: 15359632 [Abstract] [Full Text] [Related]